Skip to content
Open access

Design, synthesis, and preliminary anticancer evaluation of diphenylpropan-1-one derivatives: in vitro, in vivo and in silico studies

Sep 2026 · RSC Advances · Vol 16, pp. 57742 - 57758 · 0 citations · 42 references
Medicine

TL;DR

A series of diphenylpropan-1-one (DPP) derivatives (4a–4i), rationally designed around a chalcone framework and synthesized via a three-step reaction sequence demonstrated encouraging preliminary anticancer potential and may serve as promising lead molecules for future investigations.

Abstract

Breast cancer is a leading cause of cancer-associated mortality and morbidity worldwide, and there is a continued need for structurally diverse anticancer agents with improved properties. The present study reports a series of diphenylpropan-1-one (DPP) derivatives (4a–4i), rationally designed around a chalcone framework and synthesized via a three-step reaction sequence. The physicochemical and spectral characterization of the synthesized derivatives was performed using spectral techniques. Their anticancer potential was evaluated through a preliminary in vitro cytotoxicity screening against the MCF-7 mammary cancer cell line, followed by an in vivo efficacy assessment using a DMBA-induced mammary cancer animal model. To explore a possible molecular target, in silico molecular docking was performed against the epidermal growth factor receptor (EGFR) tyrosine kinase domain as an exploratory computational analysis. Amongst the synthesized derivatives, compound 4h demonstrated the most potent cytotoxic effects (IC50 = 1.7 µg mL−1), comparable to the standard drug gefitinib (IC50 = 1.8 µg mL−1). The in vivo studies revealed a significant and dose-dependent decline in cellular proliferation and mammary gland tumor progression, along with histopathological abnormalities upon treatment with compound 4h. Interestingly, the quantitative gene expression analysis demonstrated a significant reduction in the DMBA-induced overexpression of BRCA1, BRCA2, and TP53 in the 4h-treated groups in a dose-dependent manner. Molecular docking studies showed favorable binding of the DPP derivatives within the EGFR active site, with compound 4h exhibiting strong affinity (binding energy = −9.2 kcal mol−1) and favorable predicted interactions in the ATP-binding region of EGFR. Computational ADMET profiling provided additional preliminary predictions of the pharmacokinetic and toxicity properties of compound 4h. The identified DPP derivatives demonstrated encouraging preliminary anticancer potential and may serve as promising lead molecules for future investigations.

Read PDF

Similar papers

Sep 2026

Design, synthesis, mechanistic evaluation, and in silico study of pyrimidine-coumarin hybrids as promising anticancer agents.

Breast and lung cancers remain among the leading causes of cancer-related mortality worldwide, highlighting the urgent need for the development of effective targeted therapeutics. In this study, a series of novel pyrimidine-coumarin hybrid derivatives were rationally designed, synthesized, and biologically evaluated fo...

R. Vinay, S. Alegaon, H. S. Basavaraja et al. · 0 citations
Open access Aug 2026

Synthesis of New 1,4-dihydropyrimidine Derivatives, Breast Cancer Anticancer, and In-silico Studies

A sustainable and environmentally friendly approach for the synthesis of novel pyrimidine Schiff base derivatives through a multicomponent grinding reaction conducted at room temperature under solvent-free conditions is reported, suggesting that compound (3) may serve as a promising lead candidate for breast cancer the...

Alaa M. Abu Alnjaa · 0 citations
Open access Oct 2026

In silico-guided synthesis and cytotoxic evaluation of novel thiazolidin-4-one derivatives on glioblastoma cell lines

This study presents the synthesis and characterization of two thiazolidin-4-one derivatives ( 7a and 7b ) and the in silico-guided biological evaluation of two novel thiazolidin-4-one derivatives, 7a and 7b for their cytotoxic activity against glioblastoma cells. The chemical structures of the synthesized c...

Farah Chafika Kaouche, N. Deniz, C. Sayil et al. · 0 citations
Open access Oct 2026

Design, Synthesis, and Anticancer Evaluation of Novel Chalcone Derivatives Bearing Piperazine and Morpholine Moieties

Cancer remains one of the leading causes of mortality worldwide, highlighting the need for novel anticancer agents with improved efficacy and selectivity. In this study, a series of chalcone derivatives bearing phenylpiperazine, 2‐fluorophenylpiperazine, and morpholine moieties (1a–g, 2a–g, and 3a–g) were designed, syn...

N. Çalışkan, F. Yılmaz, O. E. Eyupoğlu et al. · 0 citations
Open access Aug 2026

Synthesis, characterization, docking and in vitro evaluation of new pyrazole-carboxylate derivatives as antibacterial, anticancer and anti-inflammatory agents

Mechanistic studies indicated that compounds 5c and 5f inhibited cancer cell growth predominantly by inducing apoptosis rather than cell cycle arrest, indicating favourable selectivity.

Rachel Alveera Menezes, Navas Shereef Ellyan, M. M. et al. · 0 citations
Open access Oct 2026

Synthesis, in vitro and in silico studies of novel N-benzoyl EF24 analogs as potential anticancer agents.

INTRODUCTION EF24, a synthetic curcumin derivative, is effective against different forms of cancers but its derivatives are underdeveloped, particularly to improve cytotoxicity and drug-receptor interactions in colorectal cancer. AREAS COVERED Nine N-benzoyl EF24 analogs were prepared and identified by Fourier transf...

Fatemeh Khademi Moughari, Ramin Ebrahimi Kiasari, G. Ghavami et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.